Motif ID: Tgif1_Meis3
Z-value: 2.943
Transcription factors associated with Tgif1_Meis3:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Meis3 | ENSMUSG00000041420.12 | Meis3 |
| Tgif1 | ENSMUSG00000047407.11 | Tgif1 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Tgif1 | mm10_v2_chr17_-_70853482_70853546 | -0.87 | 3.2e-18 | Click! |
| Meis3 | mm10_v2_chr7_+_16175085_16175139 | 0.44 | 6.7e-04 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 17.3 | 69.3 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 11.2 | 44.8 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 7.5 | 7.5 | GO:0060347 | ventricular cardiac muscle cell development(GO:0055015) heart trabecula formation(GO:0060347) |
| 7.0 | 20.9 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
| 7.0 | 13.9 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 5.8 | 23.1 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
| 5.1 | 15.4 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 5.0 | 14.9 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 4.5 | 22.3 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 4.3 | 21.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 4.2 | 16.6 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
| 4.1 | 8.2 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 3.9 | 23.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 3.9 | 50.8 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 3.9 | 15.5 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 3.7 | 18.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 3.5 | 6.9 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 3.3 | 16.5 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
| 3.3 | 9.8 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 3.3 | 13.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 3.2 | 9.5 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 3.1 | 21.8 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 2.9 | 5.8 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 2.8 | 8.3 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 2.8 | 11.0 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 2.7 | 24.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
| 2.6 | 7.8 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 2.6 | 7.8 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
| 2.6 | 7.8 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 2.5 | 12.7 | GO:0051182 | coenzyme transport(GO:0051182) |
| 2.5 | 7.6 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 2.5 | 7.5 | GO:0007403 | glial cell fate determination(GO:0007403) |
| 2.5 | 14.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 2.4 | 9.8 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 2.4 | 9.6 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 2.4 | 11.8 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 2.2 | 2.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 2.2 | 6.6 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 2.1 | 17.0 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 2.1 | 14.8 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 2.1 | 10.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 2.1 | 12.4 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 2.0 | 6.1 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 2.0 | 8.0 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
| 2.0 | 6.0 | GO:0043379 | memory T cell differentiation(GO:0043379) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 2.0 | 5.9 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 1.9 | 7.7 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
| 1.9 | 7.6 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 1.9 | 13.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 1.8 | 22.0 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 1.8 | 9.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 1.8 | 14.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 1.8 | 14.3 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 1.8 | 10.7 | GO:0019695 | choline metabolic process(GO:0019695) |
| 1.8 | 21.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 1.8 | 24.5 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 1.7 | 8.5 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
| 1.7 | 6.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 1.6 | 4.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.6 | 4.9 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 1.6 | 1.6 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 1.6 | 4.8 | GO:0002159 | desmosome assembly(GO:0002159) |
| 1.6 | 4.7 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
| 1.5 | 4.6 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) regulation of microglial cell activation(GO:1903978) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 1.5 | 10.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 1.5 | 4.5 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 1.5 | 2.9 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 1.4 | 4.3 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 1.4 | 4.3 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 1.4 | 5.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 1.4 | 7.1 | GO:0090292 | nuclear migration along microfilament(GO:0031022) nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 1.4 | 4.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 1.4 | 12.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 1.4 | 5.5 | GO:1990743 | protein sialylation(GO:1990743) |
| 1.4 | 4.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 1.4 | 25.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 1.4 | 10.9 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 1.3 | 40.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 1.3 | 5.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
| 1.3 | 15.8 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 1.3 | 6.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 1.3 | 3.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 1.3 | 6.5 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 1.3 | 1.3 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 1.3 | 9.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 1.3 | 3.8 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 1.3 | 3.8 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
| 1.3 | 1.3 | GO:0071317 | cellular response to isoquinoline alkaloid(GO:0071317) |
| 1.3 | 7.5 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 1.2 | 3.7 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 1.2 | 5.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 1.2 | 3.7 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
| 1.2 | 4.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 1.2 | 8.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 1.2 | 6.1 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 1.2 | 3.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 1.2 | 7.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 1.2 | 3.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 1.2 | 4.8 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
| 1.2 | 3.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 1.2 | 10.5 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 1.2 | 3.5 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) endosome to plasma membrane protein transport(GO:0099638) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 1.2 | 5.8 | GO:0070417 | cellular response to cold(GO:0070417) |
| 1.2 | 6.9 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
| 1.1 | 6.8 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 1.1 | 1.1 | GO:0015866 | ADP transport(GO:0015866) |
| 1.1 | 3.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 1.1 | 9.8 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 1.1 | 3.3 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
| 1.1 | 5.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 1.1 | 3.3 | GO:0070428 | granuloma formation(GO:0002432) negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) toll-like receptor 5 signaling pathway(GO:0034146) regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
| 1.1 | 3.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 1.1 | 8.6 | GO:0060373 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 1.1 | 3.2 | GO:0015867 | ATP transport(GO:0015867) |
| 1.1 | 8.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 1.1 | 5.3 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
| 1.1 | 1.1 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 1.1 | 3.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 1.0 | 3.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
| 1.0 | 3.1 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 1.0 | 8.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 1.0 | 3.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 1.0 | 10.1 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 1.0 | 24.1 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
| 1.0 | 11.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 1.0 | 2.0 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 1.0 | 13.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 1.0 | 2.9 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 1.0 | 3.9 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 1.0 | 3.9 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 1.0 | 6.8 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 1.0 | 3.9 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.0 | 2.9 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 1.0 | 5.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 1.0 | 3.8 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.0 | 5.7 | GO:0051013 | microtubule severing(GO:0051013) |
| 1.0 | 2.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 1.0 | 7.6 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.9 | 2.8 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.9 | 6.6 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.9 | 3.7 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
| 0.9 | 8.4 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.9 | 12.9 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.9 | 3.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.9 | 3.6 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
| 0.9 | 10.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.9 | 6.3 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
| 0.9 | 9.9 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
| 0.9 | 7.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.9 | 2.6 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.9 | 2.6 | GO:1903061 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.9 | 7.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.8 | 4.2 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.8 | 0.8 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.8 | 8.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.8 | 2.5 | GO:0009182 | purine deoxyribonucleotide biosynthetic process(GO:0009153) purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) glycoprotein transport(GO:0034436) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.8 | 9.0 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.8 | 5.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.8 | 2.4 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
| 0.8 | 3.2 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
| 0.8 | 5.6 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.8 | 31.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.8 | 2.4 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.8 | 4.8 | GO:0046549 | retinal cone cell development(GO:0046549) |
| 0.8 | 3.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.8 | 2.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.8 | 7.0 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.8 | 2.3 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.8 | 4.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.8 | 3.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.8 | 2.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
| 0.7 | 2.2 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
| 0.7 | 6.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.7 | 0.7 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
| 0.7 | 2.2 | GO:0043181 | vacuolar sequestering(GO:0043181) |
| 0.7 | 2.2 | GO:0007181 | epicardial cell to mesenchymal cell transition(GO:0003347) transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.7 | 9.5 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.7 | 2.2 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
| 0.7 | 5.8 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.7 | 3.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.7 | 2.1 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.7 | 2.8 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.7 | 46.0 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.7 | 4.9 | GO:0015862 | uridine transport(GO:0015862) |
| 0.7 | 3.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.7 | 1.4 | GO:0060022 | hard palate development(GO:0060022) |
| 0.7 | 2.1 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.7 | 3.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.7 | 16.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
| 0.7 | 3.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.7 | 3.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.7 | 27.1 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.7 | 2.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.7 | 1.3 | GO:1905203 | regulation of connective tissue replacement(GO:1905203) |
| 0.7 | 3.3 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.7 | 3.3 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
| 0.7 | 2.0 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.7 | 2.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.7 | 6.6 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.7 | 2.6 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 0.6 | 3.2 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.6 | 1.9 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.6 | 6.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.6 | 7.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.6 | 2.4 | GO:0061724 | lipophagy(GO:0061724) |
| 0.6 | 3.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.6 | 4.2 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.6 | 2.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
| 0.6 | 5.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.6 | 0.6 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
| 0.6 | 2.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
| 0.6 | 1.7 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.6 | 7.5 | GO:0030953 | astral microtubule organization(GO:0030953) |
| 0.6 | 1.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.6 | 8.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.6 | 2.9 | GO:0021508 | floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
| 0.6 | 2.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.6 | 5.1 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.6 | 1.7 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.6 | 2.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.5 | 7.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.5 | 3.3 | GO:1903056 | positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.5 | 1.6 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.5 | 2.7 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.5 | 9.6 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
| 0.5 | 9.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.5 | 3.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.5 | 1.1 | GO:0060266 | regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 0.5 | 0.5 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.5 | 2.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.5 | 2.1 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 0.5 | 1.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.5 | 2.1 | GO:0008078 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) mesodermal cell migration(GO:0008078) |
| 0.5 | 3.2 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.5 | 1.6 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.5 | 1.6 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
| 0.5 | 7.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.5 | 3.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.5 | 7.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.5 | 2.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.5 | 3.0 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.5 | 4.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.5 | 7.5 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
| 0.5 | 2.0 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.5 | 3.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 0.5 | 3.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.5 | 4.5 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.5 | 2.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.5 | 2.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.5 | 11.8 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
| 0.5 | 1.5 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
| 0.5 | 10.3 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.5 | 2.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.5 | 10.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
| 0.5 | 5.3 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.5 | 0.5 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.5 | 4.3 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.5 | 1.4 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.5 | 1.9 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.5 | 0.9 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
| 0.5 | 2.3 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.5 | 4.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.5 | 0.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.5 | 1.4 | GO:0003345 | proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 0.5 | 2.7 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
| 0.5 | 2.7 | GO:0051775 | response to redox state(GO:0051775) |
| 0.4 | 1.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.4 | 1.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.4 | 2.2 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.4 | 4.9 | GO:2000480 | regulation of cAMP-dependent protein kinase activity(GO:2000479) negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.4 | 0.9 | GO:0070474 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.4 | 3.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.4 | 0.4 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.4 | 18.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.4 | 2.6 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.4 | 6.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.4 | 3.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.4 | 4.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.4 | 5.9 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.4 | 1.3 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.4 | 5.8 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.4 | 14.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.4 | 7.5 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.4 | 5.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.4 | 0.4 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.4 | 1.2 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 0.4 | 3.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.4 | 1.6 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.4 | 2.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.4 | 3.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.4 | 14.6 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.4 | 2.7 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.4 | 1.6 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
| 0.4 | 3.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.4 | 0.4 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
| 0.4 | 1.5 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.4 | 2.3 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.4 | 1.1 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.4 | 2.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.4 | 3.4 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.4 | 1.1 | GO:0045658 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.4 | 1.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.4 | 2.3 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.4 | 1.1 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.4 | 29.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.4 | 6.7 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.4 | 1.9 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.4 | 1.5 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
| 0.4 | 2.6 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 0.4 | 6.5 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.4 | 1.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.4 | 2.5 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.4 | 0.7 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.4 | 0.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 0.4 | 6.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.4 | 1.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
| 0.4 | 1.4 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.4 | 1.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.4 | 1.8 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.3 | 5.6 | GO:0002335 | mature B cell differentiation(GO:0002335) |
| 0.3 | 1.7 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.3 | 1.4 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.3 | 2.1 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.3 | 4.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.3 | 21.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.3 | 2.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.3 | 1.7 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.3 | 1.0 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.3 | 3.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.3 | 1.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.3 | 0.7 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 0.3 | 3.3 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.3 | 1.3 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.3 | 1.0 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.3 | 0.3 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
| 0.3 | 1.9 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.3 | 3.5 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.3 | 3.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.3 | 2.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.3 | 3.8 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.3 | 2.5 | GO:0046541 | saliva secretion(GO:0046541) |
| 0.3 | 1.6 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.3 | 1.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.3 | 0.9 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.3 | 0.3 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.3 | 2.2 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.3 | 4.3 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.3 | 2.1 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.3 | 1.5 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.3 | 3.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.3 | 1.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.3 | 0.3 | GO:0032811 | regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) |
| 0.3 | 1.8 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.3 | 2.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.3 | 0.9 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.3 | 8.0 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 0.3 | 0.9 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.3 | 1.5 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.3 | 4.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.3 | 0.3 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
| 0.3 | 2.6 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.3 | 6.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.3 | 0.6 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
| 0.3 | 3.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.3 | 0.8 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
| 0.3 | 7.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.3 | 5.2 | GO:0032094 | response to food(GO:0032094) |
| 0.3 | 0.5 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
| 0.3 | 1.1 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) positive regulation of cytoplasmic translation(GO:2000767) |
| 0.3 | 5.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.3 | 2.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.3 | 0.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.3 | 3.5 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.3 | 3.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.3 | 17.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.3 | 4.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.3 | 1.1 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.3 | 0.8 | GO:0036216 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.3 | 2.9 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.3 | 2.4 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.3 | 1.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.3 | 1.6 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
| 0.3 | 0.3 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.3 | 1.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.3 | 0.8 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.3 | 1.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.3 | 1.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.3 | 0.5 | GO:0051305 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
| 0.3 | 4.1 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.3 | 0.8 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.2 | 0.7 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
| 0.2 | 0.5 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.2 | 1.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.2 | 4.1 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
| 0.2 | 2.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.2 | 1.7 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.2 | 0.5 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.2 | 5.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.2 | 6.3 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.2 | 5.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 | 0.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.2 | 3.1 | GO:0003016 | respiratory system process(GO:0003016) |
| 0.2 | 0.9 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.2 | 5.4 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.2 | 0.9 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.2 | 1.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.2 | 1.1 | GO:0097646 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.2 | 22.3 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
| 0.2 | 1.9 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.2 | 4.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.2 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 | 3.1 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.2 | 3.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.2 | 1.2 | GO:0006983 | ER overload response(GO:0006983) |
| 0.2 | 1.2 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.2 | 0.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.2 | 2.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.2 | 0.8 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.2 | 2.0 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 | 1.0 | GO:0015692 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.2 | 0.8 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.2 | 2.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.2 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.2 | 8.2 | GO:0030042 | actin filament depolymerization(GO:0030042) |
| 0.2 | 0.8 | GO:0097298 | regulation of nucleus size(GO:0097298) |
| 0.2 | 1.8 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.2 | 1.6 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 1.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.2 | 0.4 | GO:0060431 | primary lung bud formation(GO:0060431) |
| 0.2 | 2.5 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
| 0.2 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.2 | 8.2 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
| 0.2 | 1.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.2 | 1.0 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 | 1.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.2 | 0.9 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 | 1.3 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.2 | 1.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.2 | 1.7 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.2 | 0.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.2 | 1.9 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.2 | 1.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.2 | 1.3 | GO:0051231 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
| 0.2 | 0.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.2 | 1.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.2 | 2.4 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.2 | 1.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.2 | 0.7 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 0.2 | 0.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
| 0.2 | 1.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.2 | 0.9 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.2 | 0.9 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.2 | 0.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.2 | 1.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 | 3.9 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 0.2 | 1.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.2 | 1.4 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.2 | 9.1 | GO:0007041 | lysosomal transport(GO:0007041) |
| 0.2 | 2.6 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
| 0.2 | 0.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 | 1.0 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
| 0.2 | 1.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
| 0.2 | 0.3 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
| 0.2 | 7.0 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
| 0.2 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
| 0.2 | 8.3 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
| 0.2 | 0.7 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.2 | 5.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 | 2.5 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
| 0.2 | 8.6 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.2 | 0.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 | 1.1 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.2 | 2.1 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
| 0.2 | 4.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.2 | 5.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.2 | 0.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 5.0 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.2 | 0.6 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.2 | 0.3 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.2 | 0.5 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.2 | 0.5 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.2 | 0.6 | GO:0015871 | choline transport(GO:0015871) negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.2 | 0.9 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.2 | 0.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.2 | 11.1 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.2 | 4.5 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.2 | 3.8 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.2 | 0.6 | GO:0048793 | pronephros development(GO:0048793) |
| 0.2 | 2.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.2 | 2.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.1 | 2.7 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.1 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 | 1.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.1 | 0.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
| 0.1 | 11.6 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.1 | 2.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
| 0.1 | 6.5 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.1 | 1.0 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.1 | 1.0 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.1 | 2.5 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.1 | 0.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 | 0.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.1 | 0.8 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
| 0.1 | 0.7 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.1 | 0.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 | 6.4 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.1 | 1.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 0.7 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
| 0.1 | 2.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 1.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.1 | 0.9 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 0.8 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 1.0 | GO:0001523 | retinoid metabolic process(GO:0001523) |
| 0.1 | 1.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.1 | 0.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 | 0.4 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.1 | 5.8 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.1 | 2.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 1.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.1 | 0.6 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 | 3.3 | GO:0043113 | receptor clustering(GO:0043113) |
| 0.1 | 1.8 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.1 | 0.6 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
| 0.1 | 1.3 | GO:0010771 | negative regulation of cell morphogenesis involved in differentiation(GO:0010771) |
| 0.1 | 1.2 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.1 | 0.2 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 | 2.1 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.1 | 6.8 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.1 | 0.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 | 0.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 | 3.2 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
| 0.1 | 1.3 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.1 | 0.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 | 1.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.1 | 0.3 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) |
| 0.1 | 0.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 0.1 | 1.5 | GO:0051209 | release of sequestered calcium ion into cytosol(GO:0051209) negative regulation of sequestering of calcium ion(GO:0051283) |
| 0.1 | 5.0 | GO:0030316 | osteoclast differentiation(GO:0030316) |
| 0.1 | 0.3 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.1 | 1.2 | GO:0015809 | arginine transport(GO:0015809) |
| 0.1 | 10.3 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 | 0.8 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 2.5 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
| 0.1 | 5.0 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
| 0.1 | 0.3 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.1 | 7.7 | GO:0008643 | carbohydrate transport(GO:0008643) |
| 0.1 | 0.7 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 | 3.1 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
| 0.1 | 2.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.1 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.1 | 0.3 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.1 | 1.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 | 0.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.1 | 1.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.1 | 0.6 | GO:0001659 | temperature homeostasis(GO:0001659) |
| 0.1 | 0.5 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 | 1.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.1 | 2.2 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
| 0.1 | 0.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 0.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 | 0.9 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.1 | 1.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.1 | 0.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.1 | 0.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 1.2 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
| 0.1 | 0.4 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 | 0.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.1 | 1.4 | GO:0019915 | lipid storage(GO:0019915) |
| 0.1 | 0.8 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.1 | 7.8 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.1 | 0.4 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 1.1 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.1 | 0.4 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.1 | 1.4 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.1 | 0.2 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 0.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.1 | 1.5 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.1 | 1.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 | 0.2 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.1 | 0.9 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.1 | 0.7 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.1 | 0.8 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 0.3 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.1 | 0.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.0 | 0.1 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
| 0.0 | 3.3 | GO:0031032 | actomyosin structure organization(GO:0031032) |
| 0.0 | 1.3 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 | 0.1 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.0 | 0.9 | GO:0048814 | regulation of dendrite morphogenesis(GO:0048814) |
| 0.0 | 1.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.0 | 2.2 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
| 0.0 | 1.7 | GO:0034614 | cellular response to reactive oxygen species(GO:0034614) |
| 0.0 | 2.5 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.0 | 0.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.0 | 0.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.0 | 0.7 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 | 1.0 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
| 0.0 | 0.1 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.0 | 0.5 | GO:0001964 | startle response(GO:0001964) |
| 0.0 | 0.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.0 | 0.2 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.0 | 0.5 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.1 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.0 | 0.4 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.0 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 | 0.5 | GO:0019835 | cytolysis(GO:0019835) |
| 0.0 | 0.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
| 0.0 | 0.3 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
| 0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.0 | 0.5 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.0 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.0 | 0.3 | GO:0035050 | embryonic heart tube development(GO:0035050) |
| 0.0 | 0.7 | GO:0007569 | cell aging(GO:0007569) |
| 0.0 | 0.4 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.0 | 1.8 | GO:0009615 | response to virus(GO:0009615) |
| 0.0 | 0.1 | GO:0010737 | protein kinase A signaling(GO:0010737) |
| 0.0 | 0.8 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.0 | 0.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 | 0.6 | GO:0051101 | regulation of DNA binding(GO:0051101) |
| 0.0 | 0.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.0 | 0.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.3 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.0 | 0.1 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.0 | 0.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.0 | 0.3 | GO:0034644 | cellular response to UV(GO:0034644) |
| 0.0 | 0.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.0 | 0.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.0 | 0.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.0 | 0.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.0 | 0.4 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 0.0 | 0.0 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.2 | 18.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 5.5 | 16.5 | GO:0072534 | perineuronal net(GO:0072534) |
| 4.6 | 73.9 | GO:0005614 | interstitial matrix(GO:0005614) |
| 4.5 | 13.4 | GO:0098830 | presynaptic endosome(GO:0098830) |
| 4.0 | 20.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
| 3.9 | 15.6 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 3.5 | 10.6 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
| 2.9 | 17.4 | GO:0097443 | sorting endosome(GO:0097443) |
| 2.6 | 15.5 | GO:0045179 | apical cortex(GO:0045179) |
| 2.0 | 18.3 | GO:0042587 | glycogen granule(GO:0042587) |
| 2.0 | 2.0 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
| 2.0 | 8.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 2.0 | 48.9 | GO:0071565 | nBAF complex(GO:0071565) |
| 1.9 | 7.5 | GO:0097441 | basilar dendrite(GO:0097441) |
| 1.8 | 25.4 | GO:0016342 | catenin complex(GO:0016342) |
| 1.7 | 5.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 1.7 | 5.2 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
| 1.7 | 15.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 1.6 | 42.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 1.6 | 49.3 | GO:0033268 | node of Ranvier(GO:0033268) |
| 1.6 | 39.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 1.6 | 14.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 1.6 | 6.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 1.6 | 8.0 | GO:1990037 | Lewy body core(GO:1990037) |
| 1.4 | 15.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 1.3 | 5.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 1.3 | 3.9 | GO:0098855 | HCN channel complex(GO:0098855) |
| 1.3 | 7.7 | GO:0071439 | clathrin complex(GO:0071439) |
| 1.3 | 15.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 1.1 | 3.3 | GO:0034657 | GID complex(GO:0034657) |
| 1.1 | 15.3 | GO:0043083 | synaptic cleft(GO:0043083) |
| 1.0 | 8.0 | GO:0042629 | mast cell granule(GO:0042629) |
| 1.0 | 3.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 1.0 | 17.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 1.0 | 4.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.9 | 5.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.9 | 5.4 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.9 | 6.3 | GO:0005638 | lamin filament(GO:0005638) |
| 0.9 | 7.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.9 | 7.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.9 | 7.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.9 | 11.3 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.8 | 11.9 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.8 | 8.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.8 | 8.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.8 | 3.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.8 | 3.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.7 | 8.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.7 | 2.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.7 | 4.4 | GO:0000235 | astral microtubule(GO:0000235) |
| 0.7 | 20.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.7 | 14.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.7 | 5.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.7 | 10.3 | GO:0030673 | axolemma(GO:0030673) |
| 0.7 | 2.8 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.7 | 3.4 | GO:0030891 | VCB complex(GO:0030891) |
| 0.7 | 2.0 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.7 | 13.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.7 | 9.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.7 | 46.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.6 | 83.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.6 | 10.2 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.6 | 3.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.6 | 4.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 0.6 | 1.9 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.6 | 7.3 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.6 | 1.8 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.6 | 1.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.6 | 6.4 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.6 | 2.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.6 | 2.8 | GO:0005921 | gap junction(GO:0005921) |
| 0.5 | 7.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.5 | 6.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.5 | 1.6 | GO:0097413 | Lewy body(GO:0097413) |
| 0.5 | 5.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.5 | 5.8 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.5 | 3.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.5 | 1.6 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.5 | 3.6 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.5 | 4.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.5 | 4.9 | GO:0098839 | postsynaptic density membrane(GO:0098839) postsynaptic specialization membrane(GO:0099634) |
| 0.5 | 12.7 | GO:0031430 | M band(GO:0031430) |
| 0.5 | 1.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.5 | 2.7 | GO:0042599 | lamellar body(GO:0042599) |
| 0.5 | 2.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.5 | 2.7 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.5 | 2.3 | GO:0070820 | tertiary granule(GO:0070820) |
| 0.4 | 6.7 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.4 | 1.3 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.4 | 4.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.4 | 3.9 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.4 | 5.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.4 | 3.3 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.4 | 9.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.4 | 1.2 | GO:0097458 | neuron part(GO:0097458) |
| 0.4 | 1.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.4 | 1.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.4 | 1.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.4 | 9.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.4 | 4.0 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.4 | 1.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.4 | 13.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.4 | 3.9 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.4 | 2.8 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.3 | 7.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.3 | 1.0 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.3 | 2.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.3 | 4.9 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.3 | 3.9 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.3 | 5.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.3 | 2.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.3 | 66.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.3 | 8.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.3 | 5.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.3 | 14.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.3 | 60.1 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.3 | 2.2 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.3 | 2.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.3 | 2.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.3 | 1.8 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.3 | 9.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.3 | 2.1 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.3 | 2.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.3 | 9.3 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.3 | 0.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.3 | 1.8 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.3 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.3 | 1.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.3 | 0.3 | GO:0001740 | Barr body(GO:0001740) |
| 0.3 | 3.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.3 | 1.6 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.3 | 1.1 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.3 | 5.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.3 | 5.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.3 | 5.0 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.3 | 22.5 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.3 | 2.6 | GO:0031045 | dense core granule(GO:0031045) |
| 0.3 | 3.1 | GO:0043196 | varicosity(GO:0043196) |
| 0.3 | 0.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.3 | 2.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.3 | 3.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.3 | 7.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.3 | 2.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.2 | 4.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.2 | 17.1 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.2 | 2.1 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.2 | 2.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.2 | 2.0 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
| 0.2 | 0.9 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.2 | 4.4 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.2 | 6.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
| 0.2 | 20.3 | GO:0016605 | PML body(GO:0016605) |
| 0.2 | 12.9 | GO:0043204 | perikaryon(GO:0043204) |
| 0.2 | 3.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.2 | 2.3 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.2 | 3.8 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.2 | 29.1 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.2 | 2.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.2 | 3.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.2 | 0.8 | GO:0001652 | granular component(GO:0001652) |
| 0.2 | 1.0 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.2 | 4.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.2 | 1.4 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.2 | 0.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.2 | 7.5 | GO:0005776 | autophagosome(GO:0005776) |
| 0.2 | 1.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 2.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) COPII vesicle coat(GO:0030127) |
| 0.2 | 6.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.2 | 2.1 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.2 | 0.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.2 | 2.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.2 | 2.7 | GO:0000145 | exocyst(GO:0000145) |
| 0.2 | 0.9 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.2 | 1.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.2 | 1.6 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.2 | 5.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.2 | 9.0 | GO:0005770 | late endosome(GO:0005770) |
| 0.2 | 6.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.2 | 8.6 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.2 | 18.8 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.2 | 1.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.2 | 15.2 | GO:0030424 | axon(GO:0030424) |
| 0.1 | 31.5 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.1 | 5.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 2.4 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.1 | 1.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 3.8 | GO:0036126 | sperm flagellum(GO:0036126) |
| 0.1 | 1.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 18.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.1 | 14.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.1 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
| 0.1 | 0.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
| 0.1 | 0.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 1.2 | GO:0005605 | basal lamina(GO:0005605) |
| 0.1 | 0.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.1 | 0.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.1 | 1.8 | GO:0030315 | T-tubule(GO:0030315) |
| 0.1 | 0.4 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.1 | 8.8 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.1 | 15.9 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.1 | 2.0 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 0.8 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
| 0.1 | 0.1 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
| 0.1 | 1.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 3.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 1.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 1.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.1 | 1.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 2.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 8.8 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
| 0.1 | 251.4 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.1 | 3.3 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.1 | 5.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.1 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 1.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 1.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 0.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 1.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 0.1 | GO:1904949 | ATPase complex(GO:1904949) |
| 0.1 | 14.2 | GO:0097708 | cytoplasmic vesicle(GO:0031410) intracellular vesicle(GO:0097708) |
| 0.0 | 3.4 | GO:0099568 | cytoplasmic region(GO:0099568) |
| 0.0 | 0.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.0 | 1.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 0.3 | GO:0002177 | manchette(GO:0002177) |
| 0.0 | 0.2 | GO:1990351 | transporter complex(GO:1990351) |
| 0.0 | 2.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 1.2 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.5 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
| 0.0 | 0.3 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.0 | 2.0 | GO:0005814 | centriole(GO:0005814) |
| 0.0 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 0.1 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
| 0.0 | 0.6 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.0 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.0 | 0.1 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.0 | 0.3 | GO:0005876 | spindle microtubule(GO:0005876) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.8 | 29.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 5.2 | 15.6 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 4.2 | 12.6 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 4.2 | 16.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 3.7 | 14.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 3.4 | 10.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 3.3 | 22.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 3.3 | 9.8 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 3.2 | 13.0 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 2.9 | 8.7 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 2.7 | 8.2 | GO:0008527 | taste receptor activity(GO:0008527) |
| 2.6 | 7.9 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
| 2.5 | 14.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 2.4 | 7.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 2.3 | 6.8 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
| 2.2 | 11.0 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 2.1 | 85.7 | GO:0030552 | cAMP binding(GO:0030552) |
| 2.1 | 8.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 2.1 | 18.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 2.0 | 6.1 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 2.0 | 2.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 2.0 | 8.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
| 2.0 | 13.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 2.0 | 23.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 1.9 | 5.8 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 1.9 | 7.7 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
| 1.9 | 5.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 1.9 | 7.5 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 1.9 | 72.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 1.8 | 7.3 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 1.7 | 11.7 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 1.6 | 6.5 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 1.6 | 6.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 1.6 | 4.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 1.6 | 12.5 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 1.5 | 9.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 1.5 | 7.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 1.5 | 10.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 1.4 | 5.8 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 1.4 | 15.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 1.4 | 4.3 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 1.4 | 35.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 1.4 | 4.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 1.4 | 30.6 | GO:0071949 | FAD binding(GO:0071949) |
| 1.4 | 4.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 1.4 | 6.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 1.3 | 30.9 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 1.3 | 6.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 1.3 | 3.9 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 1.3 | 21.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 1.3 | 3.8 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 1.3 | 5.0 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
| 1.3 | 13.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 1.2 | 8.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 1.2 | 9.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 1.2 | 8.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 1.1 | 4.6 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
| 1.1 | 6.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 1.1 | 3.4 | GO:0097016 | L27 domain binding(GO:0097016) |
| 1.1 | 6.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 1.1 | 4.5 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
| 1.1 | 6.7 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 1.1 | 3.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 1.0 | 11.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 1.0 | 3.1 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
| 1.0 | 4.2 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 1.0 | 9.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 1.0 | 6.1 | GO:0089720 | caspase binding(GO:0089720) |
| 1.0 | 3.0 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 1.0 | 5.0 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 1.0 | 5.9 | GO:0045545 | syndecan binding(GO:0045545) |
| 1.0 | 3.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 1.0 | 13.7 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.9 | 21.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
| 0.9 | 6.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.9 | 4.6 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.9 | 3.6 | GO:0034481 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) chondroitin sulfotransferase activity(GO:0034481) |
| 0.9 | 12.2 | GO:0031005 | filamin binding(GO:0031005) |
| 0.9 | 1.7 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.9 | 8.7 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.8 | 2.5 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.8 | 7.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.8 | 9.0 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.8 | 6.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.8 | 3.2 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.8 | 2.4 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.8 | 2.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.8 | 11.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.8 | 13.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.8 | 2.3 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.8 | 18.8 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.7 | 5.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.7 | 2.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 0.7 | 2.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.7 | 4.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.7 | 4.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.7 | 11.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.7 | 1.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.7 | 6.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.7 | 2.0 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
| 0.7 | 0.7 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
| 0.7 | 13.2 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.7 | 11.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.7 | 2.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.7 | 2.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.6 | 7.8 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.6 | 7.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.6 | 14.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.6 | 6.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.6 | 1.3 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
| 0.6 | 1.9 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.6 | 10.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.6 | 2.5 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.6 | 11.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.6 | 35.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.6 | 2.4 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.6 | 2.4 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.6 | 6.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.6 | 4.7 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
| 0.6 | 31.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.6 | 10.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.6 | 1.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.6 | 6.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.6 | 3.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.6 | 5.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.6 | 2.3 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.6 | 9.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.6 | 5.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.6 | 12.3 | GO:0043394 | proteoglycan binding(GO:0043394) |
| 0.6 | 2.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.5 | 7.1 | GO:0043495 | protein anchor(GO:0043495) |
| 0.5 | 20.1 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.5 | 8.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.5 | 3.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.5 | 1.6 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.5 | 15.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.5 | 1.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.5 | 2.6 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
| 0.5 | 3.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.5 | 9.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.5 | 2.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.5 | 5.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.5 | 4.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.5 | 9.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.5 | 3.0 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.5 | 6.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.5 | 1.5 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.5 | 7.2 | GO:0005537 | mannose binding(GO:0005537) |
| 0.5 | 2.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.5 | 3.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.5 | 5.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.5 | 1.9 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.5 | 7.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.5 | 2.3 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.5 | 21.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.4 | 2.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.4 | 2.2 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.4 | 9.8 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.4 | 8.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.4 | 12.8 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.4 | 2.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.4 | 1.7 | GO:0035473 | lipase binding(GO:0035473) |
| 0.4 | 2.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.4 | 2.2 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.4 | 1.7 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.4 | 3.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.4 | 49.2 | GO:0008201 | heparin binding(GO:0008201) |
| 0.4 | 1.7 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.4 | 2.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.4 | 2.9 | GO:0071253 | connexin binding(GO:0071253) |
| 0.4 | 3.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.4 | 1.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.4 | 2.1 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.4 | 22.1 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.4 | 3.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.4 | 24.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.4 | 3.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.4 | 4.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.4 | 2.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.4 | 16.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.4 | 4.7 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
| 0.4 | 2.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.4 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.4 | 10.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.4 | 2.7 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.4 | 1.9 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.4 | 2.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.4 | 1.5 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
| 0.4 | 2.3 | GO:0070728 | leucine binding(GO:0070728) |
| 0.4 | 1.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.4 | 4.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.4 | 5.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.3 | 3.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.3 | 12.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.3 | 1.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.3 | 1.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.3 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.3 | 6.8 | GO:0031402 | sodium ion binding(GO:0031402) |
| 0.3 | 5.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.3 | 4.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.3 | 1.0 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
| 0.3 | 3.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.3 | 0.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.3 | 0.9 | GO:0019863 | IgE binding(GO:0019863) |
| 0.3 | 1.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.3 | 2.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.3 | 1.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.3 | 0.9 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.3 | 6.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.3 | 2.1 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.3 | 2.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.3 | 0.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.3 | 45.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.3 | 6.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.3 | 6.5 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.3 | 1.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.3 | 2.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.3 | 0.8 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.3 | 2.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.3 | 2.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.3 | 1.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.3 | 1.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.3 | 1.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.3 | 2.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.3 | 7.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.2 | 6.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.2 | 0.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.2 | 8.6 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
| 0.2 | 1.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.2 | 5.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.2 | 1.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.2 | 8.5 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.2 | 20.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.2 | 3.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.2 | 3.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.2 | 2.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.2 | 0.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.2 | 8.0 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.2 | 2.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.2 | 14.3 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.2 | 2.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
| 0.2 | 8.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.2 | 4.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.2 | 0.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.2 | 2.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.2 | 3.8 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.2 | 14.5 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
| 0.2 | 0.4 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.2 | 1.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.2 | 3.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.2 | 0.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.2 | 1.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.2 | 3.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.2 | 1.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 0.2 | 1.0 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.2 | 1.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.2 | 7.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.2 | 1.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.2 | 2.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 0.2 | 19.3 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.2 | 1.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.2 | 1.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) N-acetyllactosamine synthase activity(GO:0003945) |
| 0.2 | 2.1 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
| 0.2 | 1.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.2 | 0.6 | GO:0004980 | melanocortin receptor activity(GO:0004977) melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.2 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.2 | 1.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.2 | 0.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.2 | 1.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.2 | 0.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.2 | 1.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.2 | 0.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.2 | 2.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.2 | 5.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.2 | 8.6 | GO:0016247 | channel regulator activity(GO:0016247) |
| 0.2 | 3.6 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 0.2 | 1.3 | GO:0022839 | ion gated channel activity(GO:0022839) |
| 0.2 | 1.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.2 | 0.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.2 | 1.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.2 | 1.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.2 | 3.5 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.2 | 2.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.2 | 2.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.2 | 0.9 | GO:0015149 | glucose transmembrane transporter activity(GO:0005355) hexose transmembrane transporter activity(GO:0015149) |
| 0.2 | 0.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 5.0 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.2 | 1.7 | GO:0019531 | secondary active sulfate transmembrane transporter activity(GO:0008271) oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 24.5 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.1 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.1 | 2.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 2.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 1.2 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.1 | 0.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 0.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.1 | 6.7 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.1 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 3.5 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.1 | 3.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 26.2 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.1 | 1.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 1.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.1 | 5.0 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 4.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 1.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 10.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 3.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.1 | 3.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 3.3 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
| 0.1 | 6.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.1 | 2.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 0.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 0.7 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.1 | 3.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.1 | 0.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 0.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.1 | 3.3 | GO:0008146 | sulfotransferase activity(GO:0008146) |
| 0.1 | 0.8 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
| 0.1 | 2.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 0.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.1 | 1.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 7.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 7.0 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) ATPase activity, coupled to movement of substances(GO:0043492) |
| 0.1 | 0.5 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.1 | 9.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 1.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 1.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.1 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.1 | 0.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 1.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 0.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 0.2 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.1 | 0.6 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
| 0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 0.2 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.1 | 4.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.1 | 0.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 1.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 0.3 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.1 | 0.8 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.1 | 29.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.1 | 3.0 | GO:0016209 | antioxidant activity(GO:0016209) |
| 0.1 | 0.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.1 | 0.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 7.8 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.1 | 1.1 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 2.6 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
| 0.1 | 1.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 1.3 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
| 0.0 | 0.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.0 | 14.2 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.0 | 0.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
| 0.0 | 0.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.0 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.0 | 0.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 9.8 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 1.4 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.0 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.0 | 0.1 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.0 | 0.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.0 | 0.7 | GO:0019209 | kinase activator activity(GO:0019209) |
| 0.0 | 0.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.0 | 0.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.0 | 0.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.0 | 0.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
| 0.0 | 0.3 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.0 | 0.4 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.0 | 0.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 1.6 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 1.2 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.0 | 0.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.0 | 1.2 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.0 | 0.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.0 | 0.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.0 | 0.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.0 | 0.0 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.0 | 0.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 57.6 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
| 0.8 | 3.1 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.8 | 22.9 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.7 | 30.4 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
| 0.7 | 35.1 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 0.6 | 3.7 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
| 0.6 | 9.2 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
| 0.6 | 18.6 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
| 0.5 | 22.9 | SIG_CHEMOTAXIS | Genes related to chemotaxis |
| 0.5 | 13.2 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.5 | 18.9 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.5 | 13.3 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
| 0.4 | 8.0 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
| 0.4 | 47.9 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
| 0.4 | 9.3 | PID_BCR_5PATHWAY | BCR signaling pathway |
| 0.4 | 2.8 | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.4 | 9.6 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.4 | 4.8 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
| 0.4 | 2.0 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.4 | 12.1 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
| 0.4 | 18.1 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
| 0.4 | 42.9 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.3 | 4.2 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 0.3 | 4.0 | PID_GMCSF_PATHWAY | GMCSF-mediated signaling events |
| 0.3 | 10.0 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.3 | 1.5 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.3 | 46.9 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
| 0.3 | 6.5 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 5.7 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
| 0.2 | 2.4 | PID_THROMBIN_PAR4_PATHWAY | PAR4-mediated thrombin signaling events |
| 0.2 | 15.9 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.2 | 7.2 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
| 0.2 | 7.7 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
| 0.2 | 0.9 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 0.4 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
| 0.2 | 1.7 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
| 0.2 | 7.3 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
| 0.2 | 3.1 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.2 | 6.7 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
| 0.2 | 7.2 | PID_LKB1_PATHWAY | LKB1 signaling events |
| 0.2 | 5.0 | PID_ERBB1_DOWNSTREAM_PATHWAY | ErbB1 downstream signaling |
| 0.2 | 3.3 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.2 | 4.4 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 4.0 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.2 | 3.3 | PID_RHOA_PATHWAY | RhoA signaling pathway |
| 0.2 | 0.3 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
| 0.2 | 2.6 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
| 0.1 | 0.7 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 1.9 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 3.0 | PID_IL6_7_PATHWAY | IL6-mediated signaling events |
| 0.1 | 1.9 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 1.7 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 1.1 | ST_INTERLEUKIN_4_PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.1 | 7.6 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 4.0 | PID_REG_GR_PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 1.5 | PID_IFNG_PATHWAY | IFN-gamma pathway |
| 0.1 | 0.7 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 1.1 | PID_INSULIN_PATHWAY | Insulin Pathway |
| 0.1 | 0.5 | PID_IL8_CXCR2_PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 1.0 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 0.5 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 0.7 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 1.0 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 1.5 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 0.8 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
| 0.1 | 4.0 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
| 0.1 | 1.9 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 1.0 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 0.7 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
| 0.0 | 0.8 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.3 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 0.3 | ST_MYOCYTE_AD_PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.8 | 11.0 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 1.6 | 68.6 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
| 1.2 | 10.6 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
| 1.2 | 41.0 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
| 1.1 | 8.0 | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 1.1 | 41.0 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 1.1 | 15.9 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
| 1.1 | 13.0 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 1.0 | 19.5 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
| 1.0 | 28.5 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
| 0.9 | 14.0 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.9 | 34.2 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.9 | 8.0 | REACTOME_ARMS_MEDIATED_ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.9 | 37.2 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.9 | 14.1 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
| 0.9 | 12.1 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.8 | 10.6 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.8 | 7.3 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.8 | 10.2 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.8 | 17.2 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
| 0.8 | 18.7 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
| 0.8 | 3.0 | REACTOME_GLYCOPROTEIN_HORMONES | Genes involved in Glycoprotein hormones |
| 0.7 | 2.2 | REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS | Genes involved in CREB phosphorylation through the activation of Ras |
| 0.7 | 2.2 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.7 | 2.2 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
| 0.7 | 10.2 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.7 | 23.6 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.7 | 3.5 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.7 | 8.4 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.7 | 7.5 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.7 | 14.0 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.7 | 15.9 | REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.7 | 21.7 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
| 0.7 | 3.9 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
| 0.6 | 5.8 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 0.6 | 5.6 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
| 0.6 | 55.1 | REACTOME_L1CAM_INTERACTIONS | Genes involved in L1CAM interactions |
| 0.6 | 2.9 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
| 0.6 | 6.8 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
| 0.6 | 22.2 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.6 | 15.1 | REACTOME_NOD1_2_SIGNALING_PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.5 | 7.0 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.5 | 4.6 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.5 | 13.5 | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.5 | 10.0 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.5 | 10.1 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.4 | 10.5 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.4 | 3.9 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.4 | 3.0 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
| 0.4 | 4.1 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.4 | 9.8 | REACTOME_CGMP_EFFECTS | Genes involved in cGMP effects |
| 0.4 | 10.9 | REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.4 | 13.7 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.4 | 16.8 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.4 | 3.9 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.4 | 4.9 | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.4 | 3.3 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.4 | 3.2 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.3 | 10.6 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.3 | 12.4 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.3 | 21.1 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
| 0.3 | 2.4 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.3 | 1.2 | REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.3 | 4.9 | REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.3 | 1.5 | REACTOME_SIGNALING_BY_NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.2 | 3.0 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.2 | 7.5 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.2 | 4.0 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.2 | 7.7 | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.2 | 4.4 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.2 | 4.0 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.2 | 3.3 | REACTOME_IL1_SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.2 | 3.7 | REACTOME_ZINC_TRANSPORTERS | Genes involved in Zinc transporters |
| 0.2 | 4.4 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.2 | 6.5 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.2 | 19.9 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.2 | 1.9 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.2 | 5.5 | REACTOME_PERK_REGULATED_GENE_EXPRESSION | Genes involved in PERK regulated gene expression |
| 0.2 | 5.7 | REACTOME_POTASSIUM_CHANNELS | Genes involved in Potassium Channels |
| 0.2 | 3.6 | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.2 | 3.2 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.2 | 8.0 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.2 | 2.0 | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.2 | 5.1 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.2 | 1.9 | REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.2 | 1.3 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.2 | 0.7 | REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.2 | 3.1 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.2 | 0.9 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
| 0.2 | 1.4 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.2 | 4.4 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
| 0.2 | 0.3 | REACTOME_SHC_RELATED_EVENTS | Genes involved in SHC-related events |
| 0.2 | 3.5 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.2 | 3.0 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.2 | 5.9 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
| 0.2 | 0.8 | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | Genes involved in Integration of energy metabolism |
| 0.2 | 2.3 | REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 1.1 | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.1 | 1.4 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 5.1 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 0.6 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 1.1 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 1.0 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | Genes involved in Acyl chain remodelling of PI |
| 0.1 | 2.6 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
| 0.1 | 1.9 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 1.4 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 0.5 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 1.6 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 2.9 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 1.5 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 1.3 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.1 | 5.0 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 3.3 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 1.0 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 1.3 | REACTOME_PURINE_SALVAGE | Genes involved in Purine salvage |
| 0.1 | 1.0 | REACTOME_SIGNALING_BY_FGFR1_MUTANTS | Genes involved in Signaling by FGFR1 mutants |
| 0.1 | 7.0 | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.1 | 3.8 | REACTOME_SIGNALING_BY_EGFR_IN_CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.1 | 3.3 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 2.0 | REACTOME_SPHINGOLIPID_METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.1 | 5.5 | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.1 | 0.5 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 2.4 | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | Genes involved in Transmission across Chemical Synapses |
| 0.1 | 0.7 | REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.1 | 1.8 | REACTOME_PEROXISOMAL_LIPID_METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.1 | 5.6 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 2.5 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 1.5 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 2.0 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 1.3 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 1.1 | REACTOME_DOUBLE_STRAND_BREAK_REPAIR | Genes involved in Double-Strand Break Repair |
| 0.0 | 0.5 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 0.6 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.5 | REACTOME_ELONGATION_ARREST_AND_RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.0 | 1.3 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 0.3 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.0 | 0.1 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.0 | 0.1 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
| 0.0 | 0.3 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.0 | 0.3 | REACTOME_MICRORNA_MIRNA_BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.0 | 1.0 | REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 0.9 | REACTOME_MEIOSIS | Genes involved in Meiosis |
| 0.0 | 0.1 | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.0 | 1.3 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
|
|
|